范尔度假村 MTN 深 沪
等待开盘 01-30 09:30:00 美东时间
131.47
-1.500
-1.13%
华盛通- 最 高134.49
- 今 开133.33
- 成交量 78.92万股
- 最 低 130.415
- 昨 收 132.97
- 总市值 48.84亿
- 52周最高 168.85
- 市盈率 静 17.47
- 换手率 2.12%
- 52周最低 123.19
- 委 比 -13.64%
- 总股本 3715.24万
- 历史最高 341.72
- 量 比 1.15
- 振 幅 3.06%
- 历史最低 -27.397
- 每 手 1
- 风险率 8.24%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Skiers Are In Trouble This Season, And One Firm's Fortunes Are Suffering
Vail Resorts reported weaker early-season metrics and warned full-year earnings will miss prior expectations.
01-15 23:37
美股大行评级 | 高盛上调谷歌目标价从330美元升至375美元；5家大行集体上调Five Below目标价最高至255美元
今日重点评级关注：HC Wainwright & Co.：维持NioCorp Developments"买入"评级，目标价从9.5美元升至11.25美元；摩根士丹利：维持Chewy"超配"评级，目标价从48美元升至51美元
01-14 11:25
Jefferies Upgrades Vail Resorts to Buy, Raises Price Target to $165
Jefferies analyst David Katz upgrades Vail Resorts (NYSE:MTN) from Hold to Buy and raises the price target from $159 to $165.
01-13 21:04
Wall Street's Most Accurate Analysts Weigh In On 3 Consumer Stocks With Over 6% Dividend Yields
During times of turbulence and uncertainty in the markets, many investors turn ...
01-12 21:33
Weather woes and late snow season weigh on Vail Resorts
As Vail Resorts (MTN) struggles to find its footing -- declining 10 of the past 11 sessions -- investors are now confronted with another headwind for the company as the National Weather Service is for...
2025-12-31 22:18
美股大行评级 | 潜在涨幅908.06%！Piper Sandler首予Palisade Bio(PALI)"超配"评级，目标价25美元
今日重点评级关注：Needham：维持Autolus Therapeutics"买入"评级，目标价从10美元升至11美元；BTIG：维持Praxis Precision Medicine"买入"评级，目标价从507美元升至843美元
2025-12-30 10:04
美股大行评级 | 潜在涨幅63.56%！拜玛林制药获Truist Securities升目标价至100美元，维持"买入"评级
今日重点评级关注：Truist Securities：维持拜玛林制药"买入"评级，目标价从80美元升至100美元；HC Wainwright & Co.：维持Savara"买入"评级，目标价从8美元升至10美元
2025-12-24 11:17
Morgan Stanley Maintains Equal-Weight on Vail Resorts, Lowers Price Target to $151
Morgan Stanley analyst Stephen Grambling maintains Vail Resorts (NYSE:MTN) with a Equal-Weight and lowers the price target from $153 to $151.
2025-12-23 19:21
美股大行评级 | 绩后分化！甲骨文遭14家大行集体下调目标价；新思科技、Planet获多家机构上调目标价！
今日重点评级关注：HC Wainwright & Co.：维持Moleculin Biotech"买入"评级，目标价从4美元升至22美元；HC Wainwright & Co.：上调Soluna Holdings评级至"买入"，目标价5美元
2025-12-12 10:24
Vail Resorts收窄亏损，倚重定价策略
美国山村度假与滑雪旅游公司Vail Resorts（MTN）周四早盘大涨5.7%。该公司报告季节性亏损扩大，营收为2.71亿美元，并提出动态票价、加大营销投...
2025-12-11 22:57
